Illumina Launches DRAGEN™ v4.3, Pioneering Breakthroughs in Genome Analysis

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of DRAGEN™ v4.3, the latest ...

June 12, 2024 | Wednesday | News
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
Bio-Sourcing and Afrigen Biologics Forge Partnership to Advance Biotherapeutics in South Africa

Technology transfer will strengthen South Africa’s pharmaceutical sovereignty and drastically reduce production costs, thus improving affordability...

June 05, 2024 | Wednesday | News
Ecolab and Repligen Unveil Groundbreaking Protein A Chromatography Resin at BIO 2024

Ecolab announced that its Purolite resin business, together with Repligen Corporation, a life sciences company focused on bioprocessing technology leader...

June 04, 2024 | Tuesday | News
FDA Launches START Program to Accelerate Rare Disease Drug Development

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological p...

June 03, 2024 | Monday | News
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine

    QIAGEN announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables seamless preparation of DNA and RNA librarie...

May 30, 2024 | Thursday | News
Sandoz's Wyost® and Jubbonti® Gain EC Approval as Biosimilar Versions of Xgeva® and Prolia®

Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines Xgeva® and Prolia® EC a...

May 22, 2024 | Wednesday | News
Xcell Biosciences Inc. and AmplifyBio Forge Alliance to Transform Engineered TCR Therapy Manufacturing

Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly ...

May 20, 2024 | Monday | News
Sartorius Expands Collaboration with NVIDIA to Accelerate Development of Advanced Therapies Through AI Integration

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platfo...

May 16, 2024 | Thursday | News
OmniAb, Inc. Showcases Breakthrough in Antibody Discovery at PEGS Boston Summit

OmniAb, Inc. announced its participation in the 20th Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omn...

May 16, 2024 | Thursday | News
German Court Invalidates Patent in NanoString vs. 10x Genomics Case

Bruker Corporation announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European ...

May 08, 2024 | Wednesday | News
QIAGEN and FBI Join Forces to Pioneer Digital PCR Assay for QIAcuity in Forensic Applications

QIAGEN announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for i...

May 08, 2024 | Wednesday | News
BBI and BioAgilytix partner to streamline and simplify bioanalytical testing

BBI Solutions OEM Limited (BBI), a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership...

May 06, 2024 | Monday | News
Novartis Fortifies RLT Pipeline with Mariana Oncology Acquisition

Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer Mariana Oncology ...

May 03, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close